fda warning letters glp-1 october 2025 news Drug Recalls and Warnings: Illegal Sales and Misleading Marketing by Novo Nordisk and Eli Lilly GLP-1 Weight-Loss Drug Demonstration Begins

Key metrics to monitor include body weight trends over weeks rather than daily fluctuations, subjective appetite ratings before and after meals, frequency and intensity of cravings throughout the day, energy levels and any changes in fatigue patterns, and digestive symptoms that might indicate the supplement or medication is affecting gut function

While the side effects are usually temporary and manageable, be aware of any more serious reactions, including dizziness, abdominal pain, or signs of low blood sugar (if youre also taking diabetes medications)

Every provider listed here offers cash-pay options without insurance often more affordable than brand-name prices with insurance

& Malik, R

For patients taking antihypertensive medications, this weight-related blood pressure reduction may result in relative hypotension if medications are not appropriately adjusted

Research shows that GLP-1 not only regulates metabolic functions but also influences brain health